ReviewCancers2023
Mixed-Method Systematic Review and Meta-Analysis of Shared Decision-Making Tools for Cancer Screening.
Review in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 3 syntheses or guidelines pooled it, 20 citations in OpenAlex.
- A mixed methods systematic review of cancer treatment decision-making in vulnerable populations.Patient education and counseling · 2026Pooled it
- Pooled it
- Integrating Shared Decision-Making into Undergraduate Oncology Education: A Pedagogical Framework.Journal of cancer education : the official journal of the American Association for Cancer Education · 2024Pooled it
- Healthy habits, better searches: behavioral predictors of cancer information access.Preventive medicine reports · 2026Article
- Development, Co-Design and Pilot Testing of Resources to Support Informed Decision-Making for Lung Cancer Screening in Australia: A Study Engaging Diverse Communities and Expert Healthcare Professionals.Health expectations : an international journal of public participation in health care and health policy · 2026Article
- Involving adult inpatients, family, partners and/or carers in measuring and monitoring patient safety in acute care hospitals: Protocol for an umbrella review.HRB open research · 2026Article
- Concordance of a Web-based Lung Cancer Risk Self-Assessment Tool With Nursing Risk Assessment.CHEST pulmonary · 2025Article
- Comparative Effectiveness of Decision Aids for Cancer-Screening Decision Making: An Overview of Reviews.Journal of general internal medicine · 2024Review
- Barriers and facilitators to cervical cancer screening among under- and neverscreened women in Flanders, Belgium - a qualitative study on community and healthcare providers' perspectives.BMC public health · 2024Article
- Perceptions and beliefs of general practitioners on their role in the cancer screening programmes in the Netherlands: a mixed-methods study.BMC primary care · 2024Article
- Primary Care Patient Interest in Multi-Cancer Early Detection for Cancer Screening.Journal of personalized medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 2 countries.
Funding
Abstract
This review aimed to synthesize evidence on the effectiveness of shared decision-making (SDM) tools for cancer screening and explored the preferences of vulnerable people and clinicians regarding the specific characteristics of the SDM tools. A mixed-method convergent segregated approach was employed, which involved an independent synthesis of quantitative and qualitative data. Articles were systematically selected and screened, resulting in the inclusion and critical appraisal of 55 studies. Results from the meta-analysis revealed that SDM tools were more effective for improving knowledge, reducing decisional conflict, and increasing screening intentions among vulnerable populations compared to non-vulnerable populations. Subgroup analyses showed minimal heterogeneity for decisional conflict outcomes measured over a six-month period. Insights from the qualitative findings revealed the complexities of clinicians' and vulnerable populations' preferences for an SDM tool in cancer screening. Vulnerable populations highly preferred SDM tools with relevant information, culturally tailored content, and appropriate communication strategies. Clinicians, on the other hand, highly preferred tools that can be easily integrated into their medical systems for efficient use and can effectively guide their practice for cancer screening while considering patients' values. Considering the complexities of patients' and clinicians' preferences in SDM tool characteristics, fostering collaboration between patients and clinicians during the creation of an SDM tool for cancer screening is essential. This collaboration may ensure effective communication about the specific tool characteristics that best support the needs and preferences of both parties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.